Deguelin, a Novel Anti-Tumorigenic Agent in Human Esophageal Squamous Cell Carcinoma
Main Authors: | Yuh Baba, Yasumasa Kato |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235239641730453X |
Similar Items
-
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma
by: Xinfang Yu, et al.
Published: (2017-12-01) -
Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma
by: Yuh Baba, et al.
Published: (2017-01-01) -
High Expression of Citron Kinase Contributes to the Development of Esophageal Squamous Cell Carcinoma
by: Wenfeng Lu, et al.
Published: (2021-07-01) -
Akt inhibitor deguelin aggravates inflammation and fibrosis in myocarditis
by: Shanshan Li, et al.
Published: (2019-11-01) -
The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts
by: Masatoshi Nukui, et al.
Published: (2018-11-01)